Compare State Street SPDR S&P Biotech ETF (XBI) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR S&P Biotech ETF vs Utilities Select Sector SPDR Fund — how do they compare? State Street SPDR S&P Biotech ETF trades at $153.85 (market cap $10.11B), while Utilities Select Sector SPDR Fund trades at $41.37 (market cap $23.60B). The key difference: Utilities Select Sector SPDR Fund is far larger — about 2.3× State Street SPDR S&P Biotech ETF's market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold State Street SPDR S&P Biotech ETF for 38 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| XBI | XLU | |
|---|---|---|
Market Cap | $10.11B | $23.60B |
Volume | 12,903,266 | 28,758,237 |
Sector | Broad Market / Factor | — |
52-Week High | $169.55 | $47.73 |
52-Week Low | $104.99 | $39.25 |
Typical Hold Time | 38 Days | 80 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
XLU trades at $41.39, up 0.58% today, with technical indicators showing a mixed but overall bullish signal. The ETF recently hit 52-week lows around $39.13 amid sector-wide pressure from rising interest rates. Moving averages suggest bullish momentum, while oscillators remain neutral with RSI at 54.66 indicating balanced momentum. Recent news highlights utility stocks as oversold, creating potential buying opportunities for defensive investors.
The outlook remains cautious due to interest rate sensitivity, but current levels may offer value for long-term investors seeking defensive exposure. Key risks include further rate hikes and regulatory challenges, while potential catalysts include AI-driven power demand and defensive positioning during market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
